Moreover, CBZ has been shown to correct the trafficking defect of ΔF508 CFTR (ABCC9), the most prevalent mutation underlying cystic fibrosis (Carlile et al., 2012). This evidence concerns the gene ABCC9 and cystic fibrosis.